GT Biopharma logo
GT Biopharma GTBP
€ 2.67 -7.86%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 16.11.2026

GT Biopharma Gesamtverbindlichkeiten | GTBP

Gesamtverbindlichkeiten Jährlich GT Biopharma

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
1.32 M - 6.63 M 5 M 10.3 M 5.66 K 19.7 M 14 M 2.68 M 18.9 M 61.9 M 30.5 M 6.48 M 6.56 M 5.23 M 5.65 M -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
61.9 M 5.66 K 13 M

Gesamtverbindlichkeiten Vierteljährlich GT Biopharma

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - 4.6 M 6.63 M 6.14 M 6.38 M 7.03 M 5 M 5.12 M 8.73 M 9.65 M 10.3 M - - - - 30.7 M - 21.2 M 19.7 M 18.8 M 16.7 M 15.5 M 14 M 13.2 M 8.95 M 5.08 M 2.68 M 2.8 M 2.68 M 18.3 M 18.9 M 17.4 M 16.2 M 20.3 M 50.6 M 24.6 M 50.6 M 50.6 M 30.5 M 30.5 M 7.02 M 6.81 M 6.48 M 6.48 M 6.48 M 6.48 M 6.56 M - - - 5.23 M - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
50.6 M 2.68 M 14.8 M

Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Gesamtverbindlichkeiten Preis % 24h Marktkapitalisierung Land
Repare Therapeutics Repare Therapeutics
RPTX
25.4 M - - $ 112 M canadaCanada
Sesen Bio Sesen Bio
SESN
58.4 M - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
14.7 M - - $ 26.8 M usaUSA
Trean Insurance Group Trean Insurance Group
TIG
1.27 B - - $ 316 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
42.8 M - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
1.07 M - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
1.84 M - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.1 B - - - russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
46.8 M - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
4.81 M - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
29.7 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
3.51 M - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
145 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
64 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
135 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
50.4 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
65.9 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
2.76 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
37.2 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
171 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
694 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.1 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
8.23 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
20.3 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
9.68 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.3 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
56.7 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
14.8 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
15 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
1.14 B - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
993 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
62.2 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
75.8 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
270 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
76.6 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
3.77 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
23.6 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
45.1 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
193 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
4.43 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
51.5 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
48.7 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
2.47 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
12.5 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
95.5 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
15.8 M - 31.87 % $ 1.61 M usaUSA